Tag: information

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or the “Company”) is pleased to announce it has successfully completed the renewal and amendment (the “Amended Revolving Facility”) of its existing revolving credit facility resulting in an $80 million revolving credit facility. The Amended Revolving Facility provides the Company with $35 million of incremental borrowing capacity, consisting of $10 million of expanded revolving credit capacity with CIBC and the introduction of $25 million of incremental revolving credit capacity with Rabobank. The Amended Revolving Facility has a maturity date of June 23, 2027, and replaces the Company's current credit facilities with CIBC, which matures on October 19, 2025. The new agreement includes an option to extend maturity by one year, to June 23, 2028.

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held

LONG BEACH, Calif. and TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., announces that, at the Company's annual and special meeting (the "Meeting") of shareholders that was held on June 20, 2025 at 11:00 a.m. (Pacific Time), the Company's shareholders passed all of the resolutions put before them.

CALGARY, Alberta, June 24, 2025 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. ("Canacol" or the "Corporation") (TSX:CNE) (OTCQX:CNNEF) (BVC:CNEC) is pleased to announce that at the annual general and special meeting held in Bogotá, Colombia‎ on June 24, 2025 (the "Meeting") holders of common shares of Canacol: (i) elected Charle Gamba, Michael Hibberd, Francisco Diaz, Gustavo Gattass, Valentina Garbarini, Silvestre Tovar Leopardi and David Winter to the Board of Directors; (ii) appointed PricewaterhouseCoopers LLP, as Canacol's auditors; and (iii) approved the unallocated awards under the Corporation's omnibus long-term incentive plan.

CUE-401, a first-in-class bispecific molecule designed to induce and expand Tregs in vivo through the co-activity of transforming TGF-β and a modified variant of IL-2